EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Digital droplet PCR TERT promoter mutational screening in fine needle aspiration cytology of thyroid lesions: A highly specific technique for pre‐operative identification of high‐risk cases

Martin Hysek iD, L Samuel Hellgren, Adam Stenman, Eva Darai-Ramqvist, Elin Ljung, Igor Schliemann, Vincenzo Condello iD, Catharina Larsson, Jan Zedenius, Kenbugul Jatta, C Christofer Juhlin iD

Diagnostic Cytopathology · 2023

DOI: 10.1002/dc.25120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostic Cytopathology, 2023. Verfasst von Martin Hysek und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroid Nodule, Telomerase. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swedish Cancer Society, Cancer Research Funds of Radiumhemmet, Stockholm County Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite the advent of comprehensive molecular testing in surgical pathology, most centers still rely on the morphological assessment of fine‐needle aspiration cytology (FNAC) to triage patients with thyroid nodules for surgery. Subsets of patients could benefit from the inclusion of molecular testing to increase the diagnostic and/or prognostic properties of the cytology analysis, including the assessment of TERT promoter mutations, an event coupled with thyroid malignancy, and poor prognosis.

Methods

In this prospective study, preoperative FNAC material from 65 cases was assessed for TERT promoter hotspot mutations C228T and C250T using the digital droplet PCR (ddPCR) technique on frozen pellets and re‐evaluated postoperatively.

Results

Our cohort consisted of 15 B‐III (23%), 26 B‐IV (40%), 1 B‐V (2%), and 23 (35%) B‐VI lesions according to the Bethesda System for Reporting Thyroid Cytopathology. TERT promoter mutations were detected in 7 cases; 4 papillary thyroid carcinomas (all with preoperative B‐VI status), two follicular thyroid carcinomas (one B‐IV and one B‐V status), and one poorly differentiated thyroid carcinoma (with B‐VI status). All mutated cases were verified by mutational analysis of tumor tissue derived from postoperative formalin‐fixed paraffin‐embedded tissue, while all cases identified as wild‐type on FNAC remained wild‐type postoperatively. Moreover, the occurrence of a TERT promoter mutation was significantly associated with malignant disease and higher Ki‐67 proliferation indices.

Conclusion

In the present cohort, we found that ddPCR is a highly specific method for detecting high‐risk TERT promoter mutations on thyroid FNAC material that could guide different surgical approaches in subsets of indeterminate lesions if reproduced in larger materials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsThyroid NoduleTelomeraseHumansBiopsy, Fine-NeedleProspective StudiesProto-Oncogene Proteins B-rafMutationPolymerase Chain Reaction

Stichwörter der Autor:innen

TERT promoter mutationdigital droplet PCRfine needle aspiration cytologypreoperativerapid on-site evaluation

Substanzen

Proto-Oncogene Proteins B-rafTERT protein, humanTelomerase

Autor:innen und Institutionen

  • Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Department of Breast, Endocrine Tumors, and Sarcoma, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Pathology, Unilabs, Solna, Sweden.

ORCID-Profile: Martin Hysek, Vincenzo Condello, C Christofer Juhlin

Förderung

  • Swedish Cancer Society
  • Cancer Research Funds of Radiumhemmet
  • Stockholm County Council
  • Swedish Society of Medicine
  • Cancerfonden
  • Stockholm läns landsting
  • Svenska Läkaresällskapet

Zitieren

APA

Hysek, M., Hellgren, L. S., Stenman, A., Darai-Ramqvist, E., Ljung, E., Schliemann, I., Condello, V., Larsson, C., Zedenius, J., Jatta, K., & Juhlin, C. C. (2023). Digital droplet PCR TERT promoter mutational screening in fine needle aspiration cytology of thyroid lesions: A highly specific technique for pre‐operative identification of high‐risk cases. Diagnostic Cytopathology. https://doi.org/10.1002/dc.25120

Vancouver

Hysek M, Hellgren LS, Stenman A, Darai-Ramqvist E, Ljung E, Schliemann I, et al. Digital droplet PCR TERT promoter mutational screening in fine needle aspiration cytology of thyroid lesions: A highly specific technique for pre‐operative identification of high‐risk cases. Diagnostic Cytopathology. 2023. doi:10.1002/dc.25120

BibTeX
@article{Hysek2023,
  author = {Hysek, Martin and Hellgren, L Samuel and Stenman, Adam and Darai-Ramqvist, Eva and Ljung, Elin and Schliemann, Igor and Condello, Vincenzo and Larsson, Catharina and Zedenius, Jan and Jatta, Kenbugul and Juhlin, C Christofer},
  title = {Digital droplet PCR TERT promoter mutational screening in fine needle aspiration cytology of thyroid lesions: A highly specific technique for pre‐operative identification of high‐risk cases},
  journal = {Diagnostic Cytopathology},
  year = {2023},
  doi = {10.1002/dc.25120}
}
Kostenlos starten →